XRAY · DENTSPLY SIRONA Inc.
Market Cap
$2.28B
Shares
199.35M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$3.68B
-3%
FY2025
Net Income
-$598M
+34.3%
FY2025
Gross Margin
50%
-1.6pp
FY2025
Operating Margin
-11.47%
+11.7pp
FY2025
Diluted EPS
-$3.00
+33%
FY2025
Operating Cash Flow
$235M
-49%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $3.64B | $3.68B | $3.79B | $3.97B | $3.92B | $4.23BG | $3.34B | $4.02B | $3.99B | $3.99B | $0 | $0 | $0 | $0 | $2.93B | $2.54B | $2.22B | $2.16B | $2.19B | $2.01B | |
| $1.84B | $1.84B | $1.84B | $1.88B | $1.8B | $1.88B | $1.68B | $1.86B | $1.92B | $1.8B | $1.74B | $1.16B | $1.32B | $1.37B | $1.37B | $1.26B | $1.09B | $1.05B | $1.04B | $969.05M | |
| $1.8B | $1.84B | $1.96B | $2.09B | $2.13B | $2.35B | $1.66B | $2.16B | $2.07B | $2.19B | $2B | $1.52B | $1.6B | $1.58B | $1.56B | $1.27B | $1.13B | $1.11B | $1.15B | $1.04B | |
| — | 50% | 51.62% | 52.61% | 54.23% | 55.47% | 49.6% | 53.8% | 51.88% | 54.8% | — | — | — | — | 53.15% | 50.18% | 50.88% | 51.24% | 52.38% | 51.78% | |
| $166M | $150M | $165M | $184M | $174M | $171M | $123M | $143M | $161M | $151.7M | $128.5M | $74.9M | $80.8M | $85.1M | $85.4M | $85.4M | $66.7M | $50.3M | $48.5M | — | |
| $1.45B | $1.44B | $1.61B | $1.61B | $1.59B | $1.55B | $1.3B | $1.59B | $1.72B | $1.67B | $1.52B | $1.08B | $1.14B | $1.14B | $1.15B | $936.85M | $738.9M | $718.23M | $735.08M | — | |
| $202M | $211M | $216M | $211M | $209M | $222M | $192M | $190M | $198M | $189.1M | $155.1M | $43.8M | $47.9M | $46.2M | $49.7M | $21M | $9M | $10.6M | $8.7M | — | |
| $349M | $352M | $349M | $343M | $328M | $347M | $334M | $323M | $331M | $316.4M | $271.7M | $122.9M | $129.1M | $127.9M | $129.2M | $85.04M | $65.91M | $65.18M | $56.93M | — | |
| $80M | $24M | $53M | $67M | $14M | $17M | — | $33.5M | $32.1M | $55.4M | $20.9M | $61.4M | $9.9M | $12M | $17.8M | $3.1M | $5.8M | $5.9M | — | — | |
| -$310M | -$422M | -$879M | -$85M | -$937M | $608M | -$3M | $353M | -$958M | -$1.56B | $454.7M | $375.2M | $445.6M | $419.2M | $381.94M | $300.73M | $380.27M | $381.24M | $380.46M | $354.89M | |
| — | -11.47% | -23.17% | -2.14% | -23.89% | 14.37% | -0.09% | 8.78% | -24.03% | -39.12% | — | — | — | — | 13.04% | 11.85% | 17.12% | 17.66% | 17.36% | 17.66% | |
| $39M | -$70M | -$530M | $258M | -$609M | $955M | $331M | $676M | -$627M | -$1.25B | $726.4M | $498.1M | $574.7M | $547.1M | $511.14M | $385.76M | $446.19M | $446.42M | $437.39M | — | |
| $91M | $88M | $69M | $81M | $65M | $61M | $48M | $30M | $37M | $38.3M | $35.9M | $55.9M | $46.9M | $49.6M | $56.85M | $43.81M | $25.09M | $21.9M | $32.53M | $23.78M | |
| — | — | — | — | — | — | $1M | $2M | $2M | $2.4M | $2M | $2.2M | $5.6M | $8.1M | $8.76M | $8.24M | $4.25M | $5.03M | $17.09M | $26.43M | |
| $54M | $24M | $12M | -$9M | -$53M | -$2M | -$1M | $12M | $35M | -$5.3M | $20.1M | $8.2M | $100K | -$8.4M | -$3.17M | $600K | -$1.78M | -$1.02M | -$10.15M | $656K | |
| — | $0 | $0 | -$4M | -$36M | -$10M | $0 | — | — | $0 | $0 | -$1.6M | -$400K | $1.1M | -$3.27M | $2.35M | -$1.1M | $0 | — | — | |
| -$347M | -$486M | -$936M | -$175M | -$1.06B | $545M | -$50M | $338M | -$958M | -$1.6B | $440.9M | $329.7M | $404.4M | $369.3M | $330.68M | $256.11M | $357.66M | $363.36M | $354.87M | $358.19M | |
| $200M | $112M | -$26M | -$43M | -$105M | $134M | $23M | $82M | $53M | -$53.2M | $9.5M | $77M | $81.1M | $52.2M | $8.92M | $11.02M | $89.23M | $88.94M | $71.6M | $98.48M | |
| -$545M | -$598M | -$910M | -$132M | -$950M | $411M | -$73M | $256M | -$1.01B | -$1.55B | $429.9M | $251.2M | $322.9M | $313.2M | $314.21M | $244.52M | $265.71M | $274.26M | $283.87M | $259.65M | |
| — | -16.25% | -23.99% | -3.33% | -24.22% | 9.71% | -2.19% | 6.36% | -25.36% | -38.81% | — | — | — | — | 10.73% | 9.64% | 11.96% | 12.7% | 12.95% | 12.92% | |
| -$1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$300K | $1.5M | -$100K | $0 | $5M | $4.28M | $2.93M | $1.63M | $154K | -$599K | $57K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | -$5.75M | $3.57M | -$3.61M | $265.71M | $274.26M | $283.87M | — | |
| -$561M | -$507M | -$1B | -$140M | -$986M | $283M | $65M | $145M | -$1.2B | -$1.14B | $318.2M | $98.3M | -$49.1M | $388.3M | $360.98M | $31.26M | $206.32M | $321.35M | $177.13M | — | |
| USD/shares | -$2.75 | -$3.00 | -$4.48 | -$0.62 | -$4.41 | $1.88 | -$0.33 | $1.15 | -$4.51 | -$6.76 | $1.97 | $1.79 | $2.28 | $2.20 | $2.22 | $1.73 | $1.85 | $1.85 | $1.90 | $1.71 |
| USD/shares | -$2.75 | -$3.00 | -$4.48 | -$0.62 | -$4.41 | $1.87 | -$0.33 | $1.14 | -$4.51 | -$6.76 | $1.94 | $1.76 | $2.24 | $2.16 | $2.18 | $1.70 | $1.82 | $1.83 | $1.87 | $1.68 |
| shares | — | 199.4M | 203.2M | 212M | 215.5M | 218.4M | 219.2M | 223.1M | 224.3M | 229.4M | 218M | 140M | 141.7M | 142.7M | 141.85M | 141.39M | 143.98M | 148.32M | 149.07M | 151.71M |
| shares | — | 199.4M | 203.2M | 212M | 215.5M | 220.2M | 219.2M | 224.4M | 224.3M | 229.4M | 221.6M | 142.5M | 144.2M | 145M | 143.95M | 143.55M | 145.99M | 150.1M | 151.68M | 154.72M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $3.69B in buybacks, $1.24B in dividends.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
1.17×
Peer median 2.46×
EV/EBIT
—
Peer median 34.53×
P/E (TTM)
—
Peer median 33.63×
Peer medians compare against the 24 similar-size Medical Instruments & Supplies companies (of 45 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Essential Dental Solutions | $1,469,000,000 | $1,454,000,000 | $1,468,000,000 | $1,427,000,000 | $1,516,000,000 | — | — | — |
| Connected Technology Solutions | $1,036,000,000 | $1,062,000,000 | $1,169,000,000 | $1,219,000,000 | $1,348,000,000 | — | — | — |
| Orthodontic and Implant Solutions | $850,000,000 | $973,000,000 | $1,040,000,000 | $1,006,000,000 | $1,064,000,000 | — | — | — |
| Wellspect Healthcare | $325,000,000 | $304,000,000 | $288,000,000 | $270,000,000 | $303,000,000 | — | — | — |
| Consumables Segment | — | — | — | — | — | $1,385,000,000 | $1,751,000,000 | $1,818,000,000 |
| Technologies and Equipment | — | — | — | — | — | $1,954,000,000 | $2,271,000,000 | $2,168,000,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Other Foreign | $2,076,000,000 | $2,035,000,000 | $2,097,000,000 | $2,082,000,000 | $2,265,000,000 | — | $2,120,000,000 | $2,167,000,000 |
| Europe | $1,576,000,000 | $1,518,000,000 | $1,550,000,000 | — | — | $1,381,000,000 | — | — |
| United States | $1,182,000,000 | $1,348,000,000 | $1,437,000,000 | $1,393,000,000 | $1,484,000,000 | $1,115,000,000 | $1,375,000,000 | $1,270,000,000 |
| Rest of the World | $922,000,000 | $927,000,000 | $978,000,000 | — | — | $843,000,000 | — | — |
| Germany | $422,000,000 | $410,000,000 | $431,000,000 | $447,000,000 | $482,000,000 | — | $478,000,000 | $494,000,000 |
| Sweden | — | — | — | — | — | — | $56,000,000 | $55,000,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Implants and Prosthetics | $623,000,000 | $674,000,000 | $701,000,000 | $709,000,000 | $791,000,000 | — | — | — |
| Equipment and Instruments | $578,000,000 | $553,000,000 | $628,000,000 | $1,356,000,000 | $1,456,000,000 | — | — | — |
| CADCAM | $458,000,000 | $509,000,000 | $541,000,000 | $1,044,000,000 | $1,194,000,000 | — | — | — |
| Orthodontics | $227,000,000 | $299,000,000 | $339,000,000 | $594,000,000 | $546,000,000 | — | — | — |
| Health Care | — | — | — | $270,000,000 | $303,000,000 | — | — | — |
| Dental Consumable Products | — | — | — | — | — | $1,337,000,000 | $1,688,000,000 | $1,740,000,000 |
| Dental Laboratory Products | — | — | — | — | — | $1,674,000,000 | $2,005,000,000 | $1,897,000,000 |
| Dental Speciality Products | — | — | — | — | — | $331,000,000 | $336,000,000 | $349,000,000 |
| Endodontic and Restorative | — | — | — | $1,167,000,000 | $1,261,000,000 | — | — | — |
| Healthcare | — | — | — | — | $303,000,000 | — | — | — |
| Implants | — | — | — | $570,000,000 | $626,000,000 | — | — | — |
| Other Consumables | — | — | — | $437,000,000 | $466,000,000 | — | — | — |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Essential Dental Solutions | $514,000,000 | $479,000,000 | $478,000,000 | $467,000,000 | $511,000,000 | — | — | — |
| Orthodontic and Implant Solutions | $108,000,000 | $80,000,000 | $156,000,000 | $193,000,000 | $217,000,000 | — | — | — |
| Wellspect Healthcare | $102,000,000 | $98,000,000 | $87,000,000 | $73,000,000 | $87,000,000 | — | — | — |
| Connected Technology Solutions | $52,000,000 | $70,000,000 | $101,000,000 | $161,000,000 | $267,000,000 | — | — | — |
| Consumables Segment | — | — | — | $495,000,000 | $539,000,000 | $316,000,000 | $447,000,000 | $462,000,000 |
| Technologies and Equipment | — | — | — | $399,000,000 | $543,000,000 | $382,000,000 | $460,000,000 | $312,000,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Essential Dental Solutions | 35% | 32.9% | 32.6% | 32.7% | 33.7% | — | — | — |
| Connected Technology Solutions | 5% | 6.6% | 8.6% | 13.2% | 19.8% | — | — | — |
| Orthodontic and Implant Solutions | 12.7% | 8.2% | 15% | 19.2% | 20.4% | — | — | — |
| Wellspect Healthcare | 31.4% | 32.2% | 30.2% | 27% | 28.7% | — | — | — |
| Consumables Segment | — | — | — | — | — | 22.8% | 25.5% | 25.4% |
| Technologies and Equipment | — | — | — | — | — | 19.5% | 20.3% | 14.4% |
Key facts
CIK
818479
CUSIP
24906P109
13F (30d)
261 filings
251 filers
Visit website
Investor relations